- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Authors
Latest:
Implementation Variation in Natural Experiments of State Health Policy InitiativesThis paper presents a method to characterize policy implementation across states to enable more nuanced impact assessments of federal healthcare delivery system and payment reforms.
Latest:
ACOs With Risk-Bearing Experience Are Likely Taking Steps to Reduce Low-Value Medical ServicesExperience with risk-based contracting best predicts active engagement of accountable care organizations in reducing low-value medical services, mainly through physician education and encouraging shared decision making.
Latest:
Testing Novel Patient Financial Incentives to Increase Breast Cancer ScreeningThis study tested 3 financial incentives encouraging breast cancer screening (mammograms) among women deemed overdue. None were effective overall; "person-centered" incentives worked in the most recently screened subgroup.
Latest:
Effect of Patient Comorbidities on Filling of Antihypertensive PrescriptionsPatients in a Medicaid managed care plan who had cardiovascular comorbidities were not more likely to fill antihypertensive prescriptions than patients without these conditions.
Latest:
Cognitive Impairment and Reduced Early Readmissions in Congestive Heart Failure?Proactive identification of cognitive impairment and compensatory destigmatized patient/familial psychoeducation regarding “forgetfulness” in hospitalized patients with congestive heart failure may reduce readmission rates substantially.
Latest:
Utilization of Lymph Node Dissection, Race/Ethnicity, and Breast Cancer OutcomesThe disparities in survival among node-positive breast cancer patients of African American and Hispanic heritage are not explained by nodal surgery utilization.
Latest:
Effect of Changing COPD Triple-Therapy Inhaler Combinations on COPD SymptomsChanging patients from an inhaled corticosteroid (ICS)/long-acting β agonist (LABA) inhaler and long-acting muscarinic agonist (LAMA) inhaler to a LAMA/LABA inhaler and a separate ICS inhaler did not appear to affect patient-reported chronic obstructive pulmonary disease (COPD) symptom scores.
Latest:
Impact of a Pharmacist-Managed Diabetes Clinic on Quality MeasuresThis study evaluated a pharmacist-managed diabetes clinic to determine its impact on diabetes-related quality measures.(For Tables and Figures, please access the PDF on last page.)
Latest:
Development and Pilot Testing of Guidelines to Monitor High-Risk Medications in the Ambulatory SettingPilot testing of guidelines for the laboratory monitoring of high-risk medications shows that monitoring is highly variable and that there is room for improvement.
Latest:
Hospital Participation in Medicare ACOs: No Change in Admission Practices and SpendingHospital accountable care organization (ACO) participation did not impact emergency department admission rates, length of stay, or costs, suggesting limited effectiveness in reducing spending for unplanned admissions and challenging hospital-led ACO cost-saving strategies.
Latest:
Cost Per Response Analysis of Strategies for Chronic Immune ThrombocytopeniaThis decision tree model estimates the cost per response and incremental cost per additional responder for romiplostim, eltrombopag, and “watch and rescue” for immune thrombocytopenia.
Latest:
The Influence of Provider Characteristics and Market Forces on Response to Financial IncentivesWe determine a specialist physician phenotype responsive to financial incentives that may be leveraged to identify physicians and markets well-suited for participation in alternative payment models.
Latest:
Common Elements in Opioid Use Disorder Guidelines for Buprenorphine PrescribingThis article presents a synthesis of opioid use disorder guidelines and a framework to link them to claims data and recognize higher-quality practice, monitor outcomes, and individualize intervention.
Latest:
Improving HCV Cure Rates in HIV-Coinfected Patients - A Real-World PerspectiveThe authors examine real-world hepatitis C virus cure rates with direct-acting antivirals among patients coinfected with HIV.
Latest:
Managing Costs and Enhancing the Value of Oncology CareManagement of high and rising costs in oncology requires a multifaceted approach using both innovative strategies and pragmatic tools. In this article, we discuss several factors that influence the costs of oncology care.
Latest:
Comparing Spending Across Medicare ProgramsAs Medicare Advantage increasingly becomes the dominant form of Medicare coverage, Congress must improve transparency of programmatic costs and benefits to promote beneficiary choice.
Latest:
Benchmarking Health-Related Quality-of-Life Data From a Clinical SettingHealth-related quality-of-life data are often collected during routine clinical care. We present a method to create nationally representative benchmarks for clinical subspecialties.
Latest:
Predicting 30-Day Emergency Department Revisits“Frequent flyers” significantly contribute to emergency department (ED) crowding. This study developed a predictive model that can be used to identify high-risk patients and reduce ED revisits.
Latest:
What Determines Successful Implementation of Inpatient Information Technology Systems?This paper reports findings from a qualitative analysis of US Department of Veterans Affairs hospitals on factors affecting success in implementing 2 information technology systems.
Latest:
Interactive Voice Response Systems for Improving Delivery of Ambulatory CareA systematic review of interactive voice response system studies showed that these interventions significantly benefit adherence to various processes of care.
Latest:
Mapping US Commercial Payers' Coverage Policies for Medical InterventionsThe authors examine the largest 20 US commercial payers’ coverage policies and identify variation in how interventions are covered and the evidence reviewed in them.
Latest:
CAR-T Cells: The Next Era in Immuno-OncologyAn update on immunotherapies and the potential impact of chimeric antigen receptor (CAR)-T cells on oncology care.
